Read further: Therapeutic Potential of FPR Agonist Cmpd17b in Hypertension-Induced End-Organ Damage
Author - Hippocrates Briefs Team
Trends in Chronic Hypertension Prevalence and Treatment During...
The management of chronic hypertension during pregnancy is crucial for reducing the risk of adverse...
Predictive Value of Physical Activity and Waist Circumference on...
The research evaluated the impact of physical activity (PA) and waist circumference (WC) on UK high...
Enhancing Clinical Trial Screening with RAG-Enabled GPT-4: A...
The study explores the application of a Retrieval-Augmented Generation (RAG)–enabled GPT-4 system...
Community-Based Strategies for Cardiovascular Risk Reduction in...
The research aimed to assess the impact of program interventions on cardiovascular disease among...
Facial Expression Analysis for Post-Stroke Detection: A...
The research focuses on developing a computerized method utilizing RGB videos to differentiate post...
Atrial Fibrillation and Thromboembolic Risks: Insights from a...
In a population-based cohort study utilizing electronic healthcare records from over 5 million...
Impact of COVID-19 Vaccination on Cardiopulmonary Events in High...
COVID-19 vaccines have demonstrated efficacy in reducing hospitalizations and mortality rates...
Impact of PFAS Exposure on Cardiovascular Health in...
Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide, influenced by various...
Xylitol and Cardiovascular Risk: Metabolomic Insights and...
Understanding the residual risks contributing to cardiovascular diseases remains a critical area of...